Vanguard Group’s Cingulate CING Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$657K Buy
151,433
+77,636
+105% +$300K ﹤0.01% 3883
2025
Q3
$289K Buy
73,797
+38,420
+109% +$166K ﹤0.01% 4061
2025
Q2
$144K Buy
35,377
+24,617
+229% +$100K ﹤0.01% 4115
2025
Q1
$46.3K Buy
+10,760
New +$46.9K ﹤0.01% 4195
2023
Q4
Sell
-513
Closed -$87.2K 4504
2023
Q3
$87.2K Hold
513
﹤0.01% 4359
2023
Q2
$114K Hold
513
﹤0.01% 4378
2023
Q1
$121K Buy
+513
New +$137K ﹤0.01% 4384

Other funds holding CING

Vanguard Group's CING Position: Q4 2025 in Review

Vanguard Group increased its Cingulate (CING) stake by 105% in Q4 2025, buying an estimated $300K and bringing the position to 151,433 shares worth $657K. The position accounts for ﹤0.01% of the portfolio, ranked #3883.

Vanguard Group first reported a position in CING in Q1 2023 and has held it in 7 quarters since. 18 funds tracked by Wall St. Rank hold CING as of Q4 2025.

  • Vanguard Group held 151,433 shares of Cingulate worth $657K as of Q4 2025.
  • Vanguard Group bought 77,636 Cingulate shares in Q4 2025, an estimated $300K.
  • Cingulate made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3883 holding.
  • Vanguard Group first reported a position in Cingulate in Q1 2023 and has held it in 7 quarters since.
  • 18 funds tracked by Wall St. Rank held Cingulate as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.